Expand AGIO Menu
AGIO MENU

AGIO Latest Press Releases

-- March 10, 2026 --

Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact The Gross Law Firm for Details- AGIO PRNewswire 9:01 AM

-- March 4, 2026 --

Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIO PRNewswire 9:00 AM

-- March 3, 2026 --

Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO PRNewswire 9:00 AM

-- March 2, 2026 --

Agios' PYRUKYND (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates Globe Newswire 7:00 AM

-- February 12, 2026 --

Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 6:30 AM

-- January 26, 2026 --

Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET Globe Newswire 7:00 AM

-- January 12, 2026 --

Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth Globe Newswire 7:00 AM

-- January 5, 2026 --

Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 Globe Newswire 7:00 AM

-- December 23, 2025 --

U.S. FDA Approves Agios' AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia Globe Newswire 7:45 PM

-- December 8, 2025 --

Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia Globe Newswire 7:00 AM

-- November 19, 2025 --

Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease Globe Newswire 7:00 AM

-- November 3, 2025 --

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition Globe Newswire 9:01 AM

-- October 30, 2025 --

Agios Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 6:30 AM

-- October 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 10:00 AM

-- October 17, 2025 --

Avanzanite Bioscience's Partner Agios Announces Positive CHMP Opinion for PYRUKYND (mitapivat) for Adults with Thalassemia Business Wire 8:15 AM
Agios' PYRUKYND (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia Globe Newswire 8:00 AM

-- October 16, 2025 --

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET Globe Newswire 7:00 AM

-- October 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PRNewswire 1:43 PM
Market Data Delayed 15 Minutes